Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans

Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infection in infants, causing significant morbidity and mortality. No vaccine or specific, effective treatment is currently available. A more complete understanding of the key components of effective host response to RSV and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Currie, Silke M., Gwyer Findlay, Emily, McFarlane, Amanda J., Fitch, Paul M., Böttcher, Bettina, Colegrave, Nick, Paras, Allan, Jozwik, Agnieszka, Chiu, Christopher, Schwarze, Jürgen, Davidson, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AAI 2016
Materias:
Infectious Disease and Host Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777919/
https://www.ncbi.nlm.nih.gov/pubmed/26873992
http://dx.doi.org/10.4049/jimmunol.1502478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777919/
https://www.ncbi.nlm.nih.gov/pubmed/26873992
http://dx.doi.org/10.4049/jimmunol.1502478

Ejemplares similares